MARKET

COEPW

COEPW

Coeptis Therapeutics Holdings Inc
NASDAQ
0.0086
-0.0032
-27.12%
Closed 15:25 02/09 EST
OPEN
0.0086
PREV CLOSE
0.0118
HIGH
0.0108
LOW
0.0085
VOLUME
22.50K
TURNOVER
--
52 WEEK HIGH
0.0500
52 WEEK LOW
0.0042
MARKET CAP
--
P/E (TTM)
-0.0025
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at COEPW last week (0202-0206)?
Weekly Report · 10h ago
Coeptis Shareholders Approve Z Squared Merger
Reuters · 4d ago
COEPTIS RECEIVES SHAREHOLDER APPROVAL TOWARDS Z SQUARED MERGER
Reuters · 4d ago
Coeptis Therapeutics Holdings Inc. held shareholder meeting
Reuters · 4d ago
Weekly Report: what happened at COEPW last week (0126-0130)?
Weekly Report · 02/02 10:20
Weekly Report: what happened at COEPW last week (0119-0123)?
Weekly Report · 01/26 10:20
Weekly Report: what happened at COEPW last week (0112-0116)?
Weekly Report · 01/19 10:26
Nasdaq Warns Coeptis Therapeutics Over Missed Annual Shareholder Meeting Deadline
Reuters · 01/16 21:35
More
About COEPW
Coeptis Therapeutics Holdings, Inc., together with its subsidiaries, including Coeptis Therapeutics, Inc., Coeptis Pharmaceuticals, Inc. and Coeptis Pharmaceuticals, LLC., is a biopharmaceutical company. The Company owns, acquires, and develops cell therapy technologies for cancer and other diseases. Its product portfolio and rights are highlighted by assets licensed from Deverra Therapeutics, including an allogeneic cellular immunotherapy platform and DVX201, a clinical-stage, unmodified natural killer cell therapy technology. It is developing a universal, multi-antigen chimeric antigen receptor (CAR) T technology licensed from the University of Pittsburgh (SNAP-CAR), and the GEAR cell therapy and companion diagnostic platforms, which the Company is developing with VyGen-Bio and medical researchers at the Karolinska Institute. Its CAR therapy is a treatment for cancer in which a patient's T cells are genetically engineered to recognize cancer cells to target and destroy them.

Webull offers Coeptis Therapeutics Holdings Inc stock information, including NASDAQ: COEPW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, COEPW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading COEPW stock methods without spending real money on the virtual paper trading platform.